Open Access

Sudden cardiac death in football players: Towards a new pre‑participation algorithm (Review)

  • Authors:
    • Sophie I. Mavrogeni
    • Konstantinos Tsarouhas
    • Demetrios A. Spandidos
    • Christina Kanaka‑Gantenbein
    • Flora Bacopoulou
  • View Affiliations

  • Published online on: November 30, 2018     https://doi.org/10.3892/etm.2018.7041
  • Pages: 1143-1148
  • Copyright: © Mavrogeni et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Athletic pre‑participation screening is essential for minimizing the risk for sudden cardiac death (SCD) in athletes participating in either competitive or leisure sporting activities. The primary causes of SCD in young athletes (<35 years of age) include hypertrophic cardiomyopathy, congenital anomalies of the coronary artery and arrhythmogenic right ventricular cardiomyopathy. Other abnormalities, such as malignant arrhythmia due to blunt trauma to the chest (commotio cordis), myocarditis, valvular disease, aortic rupture (in Marfan syndrome) and ion channelopathies (catecholaminergic polymorphic ventricular tachycardia, Brugada syndrome, long or short QT syndrome), also contribute to a lesser degree to SCD. Currently, clinical assessment, electrocardiogram (ECG) and echocardiography are the cornerstones of the pre‑participation athletic evaluation. However, their low sensitivity raises queries as regards the need for the application of more sophisticated modalities, such as cardiovascular magnetic resonance (CMR). CMR offers precise biventricular assessment and is greatly reproducible without the inherent limitations of echocardiography; i.e., low quality of images due to the lack of appropriate acoustic window or operator's experience. Furthermore, myocardium replacement fibrosis, indicative of patients' increased risk for future cardiac events, can be effectively detected by late gadolinium enhanced (LGE) images, acquired 15 min post‑contrast injection. Finally, diffuse myocardial fibrosis not identified by LGE, can also be detected by pre‑contrast (native) T1, post‑contrast T1 mapping and extracellular volume images, which provide detailed information about the underlying pathophysiologic background. Therefore, CMR is recommended in all football players with a positive family or personal history of syncope or SCD, abnormal/doubtful ECG or echocardiogram.
View References

Related Articles

Journal Cover

February-2019
Volume 17 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Mavrogeni SI, Tsarouhas K, Spandidos DA, Kanaka‑Gantenbein C and Bacopoulou F: Sudden cardiac death in football players: Towards a new pre‑participation algorithm (Review). Exp Ther Med 17: 1143-1148, 2019
APA
Mavrogeni, S.I., Tsarouhas, K., Spandidos, D.A., Kanaka‑Gantenbein, C., & Bacopoulou, F. (2019). Sudden cardiac death in football players: Towards a new pre‑participation algorithm (Review). Experimental and Therapeutic Medicine, 17, 1143-1148. https://doi.org/10.3892/etm.2018.7041
MLA
Mavrogeni, S. I., Tsarouhas, K., Spandidos, D. A., Kanaka‑Gantenbein, C., Bacopoulou, F."Sudden cardiac death in football players: Towards a new pre‑participation algorithm (Review)". Experimental and Therapeutic Medicine 17.2 (2019): 1143-1148.
Chicago
Mavrogeni, S. I., Tsarouhas, K., Spandidos, D. A., Kanaka‑Gantenbein, C., Bacopoulou, F."Sudden cardiac death in football players: Towards a new pre‑participation algorithm (Review)". Experimental and Therapeutic Medicine 17, no. 2 (2019): 1143-1148. https://doi.org/10.3892/etm.2018.7041